ABCD Study Results: Will Noninvasive T-Wave Test Boost ICD Referrals?
This article was originally published in The Gray Sheet
Executive Summary
Data presented Nov. 15 helps validate microvolt t-wave alternans (MTWA) analysis for identifying certain patients at high risk for sudden cardiac death, but questions remain about the test's potential impact on physician practice
You may also be interested in...
HRS Features Data On ICD Survival, MRI-Safe Pacers, Device Replacements
Encouraging results on defibrillator survival rates and imaging-safe pacemakers, along with more detailed outcomes data from device replacements, were among the biggest take-away items from the Heart Rhythm Society's annual scientific sessions held in Boston earlier this month
HRS Features Data On ICD Survival, MRI-Safe Pacers, Device Replacements
Encouraging results on defibrillator survival rates and imaging-safe pacemakers, along with more detailed outcomes data from device replacements, were among the biggest take-away items from the Heart Rhythm Society's annual scientific sessions held in Boston earlier this month
T-Wave Alternans ICD Screening May Gain Traction With St. Jude Pact
St. Jude Medical's endorsement of microvolt t-wave alternans testing under a co-marketing agreement with test maker Cambridge Heart will help accelerate adoption of the technology, which guides appropriate defibrillator patient selection, both companies say